{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:17:35Z","timestamp":1760145455636,"version":"build-2065373602"},"reference-count":49,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003712","name":"Korea Food Research Institute (KFRI)","doi-asserted-by":"publisher","award":["E0210203-04"],"award-info":[{"award-number":["E0210203-04"]}],"id":[{"id":"10.13039\/501100003712","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a major issue because it is closely associated with metabolic diseases. Advanced glycation end products (AGEs) are implicated as risk factors for steatosis during NAFLD progression. AGEs influence NAFLD progression through a receptor-independent pathway involving AGE cross-link formation and a receptor-dependent pathway that binds to receptors like receptors for advanced glycation end products (RAGE). The objectives of this study are to examine the effect of Lindera obtusiloba Blume (LO) on NAFLD promoted by N\u03b5-(carboxymethyl)lysine (CML), one of the most common dietary AGEs. The anti-glycation effects of LO were evaluated by inhibiting the AGEs formation and AGEs-collagen cross-links breaking. The efficacy of LO against NAFLD promoted by CML was assessed using both in vitro and in vivo models. NAFLD was induced in mice by feeding a high-fat diet and orally administering CML over a period of 12 weeks, and the effects of LO on lipid metabolism and its regulatory mechanisms were investigated. LO showed the effect of inhibited AGEs formation and breakage, and collagen cross-linking. Fed a high-fat diet with administered CML by gavage, LO administration resulted in a reduction in body weight, fat mass, serum triglycerides, total cholesterol, and low-density lipoprotein cholesterol levels. LO reduced hepatic CML accumulation and RAGE expression in mice fed a high-fat diet and orally administered CML. LO alleviated hepatic steatosis accompanied by lipid accumulation and histological damage by suppressing the expression of sterol regulatory element-binding protein 1c, carbohydrate response element binding protein, fatty acid synthase, stearoyl-CoA desaturase1, tumor necrosis factor-\u03b1, and interleukin-1\u03b2. LO alleviated the MAPK\/NF-\u03baB expression by attenuating CML and RAGE expression. Taken together, our results demonstrate that LO alleviates the progression of NAFLD by lowering the levels of AGEs by downregulating CML\/RAGE expression.<\/jats:p>","DOI":"10.3390\/nu16142330","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T13:12:57Z","timestamp":1721394777000},"page":"2330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by N\u03b5-(carboxymethyl)lysine"],"prefix":"10.3390","volume":"16","author":[{"given":"Jin-Ah","family":"Lee","sequence":"first","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3300-7548","authenticated-orcid":false,"given":"Min Ji","family":"Gu","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1258-5363","authenticated-orcid":false,"given":"Yu Ra","family":"Lee","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoonsook","family":"Kim","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inwook","family":"Choi","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0139-2494","authenticated-orcid":false,"given":"Donghwan","family":"Kim","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3329-2279","authenticated-orcid":false,"given":"Sang Keun","family":"Ha","sequence":"additional","affiliation":[{"name":"Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea"},{"name":"Division of Food Biotechnology, University of Science and Technology, Daejeon 34113, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e0251","DOI":"10.1097\/HC9.0000000000000251","article-title":"The burden of nonalcoholic fatty liver disease (NAFLD) is rapidly growing in every region of the world from 1990 to 2019","volume":"7","author":"Paik","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hydes, T., Alam, U., and Cuthbertson, D.J. (2021). The Impact of Macronutrient Intake on Non-alcoholic Fatty Liver Disease (NAFLD): Too Much Fat, Too Much Carbohydrate, or Just Too Many Calories?. Front. Nutr., 8.","DOI":"10.3389\/fnut.2021.640557"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1017\/jns.2021.30","article-title":"The burden of excessive saturated fatty acid intake attributed to ultra-processed food consumption: A study conducted with nationally representative cross-sectional studies from eight countries","volume":"10","author":"Steele","year":"2021","journal-title":"J. Nutr. Sci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/10715762.2013.815348","article-title":"Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): An overview of their mechanisms of formation","volume":"47","author":"Vistoli","year":"2013","journal-title":"Free Radic. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10719-022-10063-x","article-title":"Advanced Glycation End Products: Key player of the pathogenesis of atherosclerosis","volume":"39","author":"Singh","year":"2022","journal-title":"Glycoconj. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/diacare.25.6.1055","article-title":"Advanced glycation end products and endothelial dysfunction in type 2 diabetes","volume":"25","author":"Tan","year":"2002","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/MOL.0b013e32835aea13","article-title":"Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity","volume":"24","author":"Gaens","year":"2013","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semcancer.2017.07.001","article-title":"AGEs, RAGEs and s-RAGE; friend or foe for cancer","volume":"49","author":"Ahmad","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2003.08.013","article-title":"Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts","volume":"419","author":"Thornalley","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1196\/annals.1333.093","article-title":"Pyridoxamine: The many virtues of a maillard reaction inhibitor","volume":"1043","author":"Voziyan","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/dom.12058","article-title":"Current therapeutic interventions in the glycation pathway: Evidence from clinical studies","volume":"15","author":"Engelen","year":"2013","journal-title":"Diabetes Obes. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"108933","DOI":"10.1016\/j.foodres.2019.108933","article-title":"Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: A comprehensive review","volume":"130","author":"Khan","year":"2020","journal-title":"Food Res. Int."},{"key":"ref_14","first-page":"685","article-title":"Identification of hub genes and key pathways of dietary advanced glycation end products-induced non-alcoholic fatty liver disease by bioinformatics analysis and animal experiments","volume":"21","author":"Wang","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Pang, Q., Sun, Z., Shao, C., Cai, H., Bao, Z., Wang, L., Li, L., Jing, L., Zhang, L., and Wang, Z. (2020). CML\/RAGE Signal Bridges a Common Pathogenesis Between Atherosclerosis and Non-alcoholic Fatty Liver. Front. Med., 7.","DOI":"10.3389\/fmed.2020.583943"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, Y., Qin, M., Zhong, W., Liu, C., Deng, G., Yang, M., Li, J., Ye, H., Shi, H., and Wu, C. (2023). RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease. Redox Biol., 59.","DOI":"10.1016\/j.redox.2022.102559"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41434-022-00351-4","article-title":"Loss of RAGE prevents chronic intermittent hypoxia-induced nonalcoholic fatty liver disease via blockade of NF-\u03baB pathway","volume":"30","author":"Tan","year":"2023","journal-title":"Gene Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Otazu, G.K., Dayyani, M., and Badie, B. (2021). Role of RAGE and Its Ligands on Inflammatory Responses to Brain Tumors. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.770472"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbamcr.2012.10.021","article-title":"RAGE in tissue homeostasis, repair and regeneration","volume":"1833","author":"Sorci","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jhep.2013.11.033","article-title":"Dietary glycotoxins exacerbate progression of experimental fatty liver disease","volume":"60","author":"Leung","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_21","unstructured":"Yook, C. (1989). Medicinal Plants of Korea, Academy Publishing Co."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lee, J.O., Auger, C., Park, D.H., Kang, M., Oak, M.H., Kim, K.R., and Schini-Kerth, V.B. (2013). An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db\/db mice. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0065227"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jnutbio.2009.09.013","article-title":"An active extract of Lindera obtusiloba inhibits adipogenesis via sustained Wnt signaling and exerts anti-inflammatory effects in the 3T3-L1 preadipocytes","volume":"21","author":"Freise","year":"2010","journal-title":"J. Nutr. Biochem."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Freise, C., Ruehl, M., Erben, U., Neumann, U., Seehofer, D., Kim, K.Y., Trowitzsch-Kienast, W., Stroh, T., Zeitz, M., and Somasundaram, R. (2011). A hepatoprotective Lindera obtusiloba extract suppresses growth and attenuates insulin like growth factor-1 receptor signaling and NF-kappaB activity in human liver cancer cell lines. BMC Complement. Altern. Med., 11.","DOI":"10.1186\/1472-6882-11-39"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ihm, S.H., Park, S.H., Lee, J.O., Kim, O.R., Park, E.H., Kim, K.R., Kim, J.H., Hwang, B.H., Youn, H.J., and Oak, M.H. (2021). A Standardized Lindera obtusiloba Extract Improves Endothelial Dysfunction and Attenuates Plaque Development in Hyperlipidemic ApoE-Knockout Mice. Plants, 10.","DOI":"10.3390\/plants10112493"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1271\/bbb.120562","article-title":"Separation of the antioxidant compound quercitrin from Lindera obtusiloba Blume and its antimelanogenic effect on B16F10 melanoma cells","volume":"77","author":"Hong","year":"2013","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: A review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Snelson, M., and Coughlan, M.T. (2019). Dietary Advanced Glycation End Products: Digestion, Metabolism and Modulation of Gut Microbial Ecology. Nutrients, 11.","DOI":"10.3390\/nu11020215"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Haque, M.E., Azam, S., Balakrishnan, R., Akther, M., and Kim, I.S. (2020). Therapeutic Potential of Lindera obtusiloba: Focus on Antioxidative and Pharmacological Properties. Plants, 9.","DOI":"10.3390\/plants9121765"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.lwt.2014.11.014","article-title":"Inhibitory effect of polyphenols in Houttuynia cordata on advanced glycation end-products (AGEs) by trapping methylglyoxal","volume":"61","author":"Yoon","year":"2015","journal-title":"LWT-Food Sci. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/cbdv.200890226","article-title":"Effects of compounds isolated from the fruits of Rumex japonicus on the protein glycation","volume":"5","author":"Jang","year":"2008","journal-title":"Chem. Biodivers."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: Old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Patel, R., Baker, S.S., Liu, W., Desai, S., Alkhouri, R., Kozielski, R., Mastrandrea, L., Sarfraz, A., Cai, W., and Vlassara, H. (2012). Effect of dietary advanced glycation end products on mouse liver. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0035143"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.3748\/wjg.v22.i35.8026","article-title":"Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease","volume":"22","author":"Leung","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Litwinowicz, K., Waszczuk, E., and Gamian, A. (2021). Advanced Glycation End-Products in Common Non-Infectious Liver Diseases: Systematic Review and Meta-Analysis. Nutrients, 13.","DOI":"10.3390\/nu13103370"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114010","DOI":"10.1016\/j.fct.2023.114010","article-title":"Dietary N(\u03b5)-(carboxymethyl)lysine is a trigger of non-alcoholic fatty liver disease under high-fat consumption","volume":"180","author":"Lee","year":"2023","journal-title":"Food Chem. Toxicol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","article-title":"Molecular mediators of hepatic steatosis and liver injury","volume":"114","author":"Browning","year":"2004","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1073\/pnas.0401516101","article-title":"Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis","volume":"101","author":"Iizuka","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/gut.2003.024935","article-title":"Cytokines and the pathogenesis of non-alcoholic steatohepatitis","volume":"54","author":"Diehl","year":"2005","journal-title":"Gut"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2011.07.028","article-title":"Endogenous formation of N\u03b5-(carboxymethyl)lysine is increased in fatty livers and induces inflammatory markers in an in vitro model of hepatic steatosis","volume":"56","author":"Gaens","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: Sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.3748\/wjg.15.5789","article-title":"Role of the receptor for advanced glycation end products in hepatic fibrosis","volume":"15","author":"Lohwasser","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1681\/ASN.V1191656","article-title":"Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease","volume":"11","author":"Tanji","year":"2000","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Su, S.C., Hung, Y.J., Huang, C.L., Shieh, Y.S., Chien, C.Y., Chiang, C.F., Liu, J.S., Lu, C.H., Hsieh, C.H., and Lin, C.M. (2019). Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE\/ERK\/NF-\u03baB signaling pathways. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0550-9"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jcsm.12561","article-title":"Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia","volume":"11","author":"Chiappalupi","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"H491","DOI":"10.1152\/ajpheart.00464.2008","article-title":"AGE\/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice","volume":"295","author":"Gao","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.vph.2015.04.004","article-title":"Decreased plasma endogenous soluble RAGE, and enhanced adipokine secretion, oxidative stress and platelet\/coagulative activation identify non-alcoholic fatty liver disease among patients with familial combined hyperlipidemia and\/or metabolic syndrome","volume":"72","author":"Santilli","year":"2015","journal-title":"Vasc. Pharmacol."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/14\/2330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:19:43Z","timestamp":1760109583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/14\/2330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":49,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["nu16142330"],"URL":"https:\/\/doi.org\/10.3390\/nu16142330","relation":{},"ISSN":["2072-6643"],"issn-type":[{"type":"electronic","value":"2072-6643"}],"subject":[],"published":{"date-parts":[[2024,7,19]]}}}